About the journal
Onco is an open-access journal published by MDPI AG in Switzerland, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 1,000 CHF. Declared review time at DOAJ: 6 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- MDPI AG
- ISSN
- 2673-7523
- Country
- Switzerland
- Languages
- english
- Access
- Open access
- Declared publication charge
- 1,000 CHF
- Articles in DOAJ
- 132
- Declared review time
- 6 weeks
- Declared peer-review model
- peer_review
- Official website
- https://www.mdpi.com/journal/onco
Index listings
- DOAJ · 2023-02-05
- Indexing
- DOAJ
- APC
- 1,000 CHF
- Declared review time (DOAJ)
- 6 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
132
Most recent article
4 months ago
Average review time (journal-declared via DOAJ)
6weeks
Works in OpenAlex
172
Last recorded publication year
2026
h-index
8
i10-index
4
From OpenAlex open data (CC0).
Editorial & policy12
- Last DOAJ review date
- 2023-02-05
- Added to DOAJ
- 2023-02-05
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSS
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSS
- Editorial board
- Official page ↗
- Open references deposited at Crossref
- 100%
- ORCID iDs in current deposits
- 89%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 9918487488706676
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
- Cancer Genomics and Diagnostics
- Cancer Genomics and Diagnostics
- Cancer, Hypoxia, and Metabolism
- Cancer, Hypoxia, and Metabolism
- Glioma Diagnosis and Treatment
- Glioma Diagnosis and Treatment
Show all subjects (50)
- Lung Cancer Treatments and Mutations
- Immunotherapy and Immune Responses
- Immunotherapy and Immune Responses
- Lung Cancer Treatments and Mutations
- Lung Cancer Research Studies
- Cancer Cells and Metastasis
- Cancer Cells and Metastasis
- Lung Cancer Research Studies
- Histone Deacetylase Inhibitors Research
- Histone Deacetylase Inhibitors Research
- Head and Neck Cancer Studies
- Ferroptosis and cancer prognosis
- Head and Neck Cancer Studies
- Cancer-related molecular mechanisms research
- Radiomics and Machine Learning in Medical Imaging
- Radiomics and Machine Learning in Medical Imaging
- Cancer-related molecular mechanisms research
- CAR-T cell therapy research
- CAR-T cell therapy research
- Ferroptosis and cancer prognosis
- Acute Lymphoblastic Leukemia research
- Cancer-related Molecular Pathways
- Pancreatic and Hepatic Oncology Research
- Ovarian cancer diagnosis and treatment
- Lung Cancer Diagnosis and Treatment
- Ovarian cancer diagnosis and treatment
- MicroRNA in disease regulation
- MicroRNA in disease regulation
- Lung Cancer Diagnosis and Treatment
- Cancer-related Molecular Pathways
- Acute Lymphoblastic Leukemia research
- Pancreatic and Hepatic Oncology Research
- Brain Metastases and Treatment
- Prostate Cancer Treatment and Research
- Melanoma and MAPK Pathways
- Brain Metastases and Treatment
- Colorectal Cancer Treatments and Studies
- Endometrial and Cervical Cancer Treatments
- Prostate Cancer Treatment and Research
- Melanoma and MAPK Pathways
- Colorectal Cancer Treatments and Studies
- Endometrial and Cervical Cancer Treatments
Keywords (DOAJ)
- targeted therapy
- oncogenes
- oncoproteins
- tumor suppressors
- signal transduction
- cellular processes
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ